1.02
Schlusskurs vom Vortag:
$1.09
Offen:
$1.06
24-Stunden-Volumen:
820.94K
Relative Volume:
1.18
Marktkapitalisierung:
$101.07M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-0.8293
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
-20.93%
1M Leistung:
-29.90%
6M Leistung:
-77.92%
1J Leistung:
-82.29%
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ALEC
Alector Inc
|
1.02 | 101.07M | 100.56M | -119.05M | -231.16M | -1.23 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
2024-12-16 | Herabstufung | Stifel | Buy → Hold |
2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2023-12-14 | Hochstufung | Stifel | Hold → Buy |
2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
2023-09-25 | Eingeleitet | Goldman | Sell |
2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-07-07 | Eingeleitet | Mizuho | Buy |
2022-04-13 | Eingeleitet | Goldman | Sell |
2022-03-08 | Herabstufung | Stifel | Buy → Hold |
2021-09-27 | Eingeleitet | William Blair | Outperform |
2021-01-15 | Fortgesetzt | BofA Securities | Buy |
2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
2020-04-28 | Eingeleitet | Goldman | Buy |
2020-03-06 | Eingeleitet | Citigroup | Buy |
2020-02-27 | Eingeleitet | Barclays | Overweight |
2020-02-19 | Eingeleitet | Stifel | Buy |
2019-11-21 | Eingeleitet | BTIG Research | Buy |
2019-03-04 | Eingeleitet | Barclays | Overweight |
2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com
Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World
Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com
Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter
Alector Announces Resignation of Chief Medical Officer - TipRanks
Alector Appoints New Chief Medical Officer - MarketScreener
Alector Provides Executive Leadership Update - The Manila Times
Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan
Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace
Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st
Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com
Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha
Mizuho’s latest rating for ALEC stock - Knox Daily
Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India
Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia
Alector announces workforce reduction to cut costs - Investing.com
Alector to Cut 13% of Workforce - MarketWatch
Have Alector Insiders Been Selling Stock? - simplywall.st
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus Target Price from Analysts - Defense World
Alector assumed with an Underweight at Morgan Stanley - TipRanks
Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies - Investing.com India
Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies By Investing.com - Investing.com UK
Alector Executives Sell Shares to Satisfy Tax Obligations - TradingView
Alector stock hits 52-week low at $1.54 amid sharp annual decline - Investing.com Australia
William Blair Predicts Alector’s Q1 Earnings (NASDAQ:ALEC) - The AM Reporter
Alector stock hits 52-week low at $1.54 amid sharp annual decline By Investing.com - Investing.com South Africa
Research Analysts Set Expectations for Alector Q1 Earnings - Defense World
Earnings Update: Alector, Inc. (NASDAQ:ALEC) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Alector Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Alector’s Earnings Call: Progress Amid Challenges - TipRanks
Alector (NASDAQ:ALEC) Releases Earnings Results, Beats Expectations By $0.59 EPS - MarketBeat
Alector Inc (ALEC) Shares Up Despite Recent Market Volatility - The News Heater
Alector, Inc. (NASDAQ:ALEC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction By Investing.com - Investing.com South Africa
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising Clinical Advances - GuruFocus.com
Alector: Q4 Earnings Snapshot - mySA
The Bold Bet on Brain Health: Alector’s Race Against Time in Neurodegenerative Research - Smartphone Magazine
Alector Inc (NASDAQ:ALEC): The Biotech Pioneering New Frontiers in Neurodegenerative Diseases - Jomfruland.net
Alector beats Q4 estimates, shares edge higher By Investing.com - Investing.com South Africa
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... - Yahoo Finance
Alector, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):